Dachaigh › Migraine › Nebraska
Sgrùdaidhean clionaigeach Migraine ann an Nebraska
Tha 8 sgrùdaidhean airson Migraine a’ lorg phàirtichean aig làraichean ann an Nebraska.
Bailtean ann an Nebraska
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital & Medical Center, Omaha
A’ fastadhÌre 1
Aoisean 6 gu 11 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Grand Island, Grand Island
- Papillion Research Center/CCT Research, Papillion
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's Hospital & Medical Center, Omaha
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's Hospital & Medical Center, Omaha
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Cct Research - Papillion Research Center /ID# 270393, Papillion
A’ fastadhÌre 3
Aoisean 12 gu 17 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nebraska Medical Center, Omaha
A’ fastadhÌre 4
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Cognitive Clinical Trials (CCT) - Papillion /ID# 232552, Papillion
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05125302Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Tri City Research Center, LLC /ID# 278800, Grand Island
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Gearr 2026 · NCT07310290Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.